| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3337212 | Hepatobiliary & Pancreatic Diseases International | 2016 | 8 Pages |
Abstract
Our results showed that suppression of tumorigenesis by CADM1 may be mediated by the Rb-E2F pathway, involving upregulation of Rb protein levels. This pathway could therefore represent an attractive target for HCC therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Wu Zhang, Hai-Yang Xie, Song-Ming Ding, Chun-Yang Xing, An Chen, Ming-Chun Lai, Lin Zhou, Shu-Sen Zheng,